Leclercia adecarboxylata as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing

MLA

Souheil Zayet, et al. “Leclercia Adecarboxylata as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing.” Pathogens, vol. 10, no. 11, Oct. 2021, p. 1399. EBSCOhost, https://doi.org/10.3390/pathogens10111399.

APA

Souheil Zayet, Stephane Lang, Pauline Garnier, Alix Pierron, Julie Plantin, Lynda Toko, Pierre-Yves Royer, Marc Villemain, Timothée Klopfenstein, & Vincent Gendrin. (2021). Leclercia adecarboxylata as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing. Pathogens, 10(11), 1399. https://doi.org/10.3390/pathogens10111399

Chicago

Souheil Zayet, Stephane Lang, Pauline Garnier, Alix Pierron, Julie Plantin, Lynda Toko, Pierre-Yves Royer, Marc Villemain, Timothée Klopfenstein, and Vincent Gendrin. 2021. “Leclercia Adecarboxylata as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing.” Pathogens 10 (11): 1399. doi:10.3390/pathogens10111399.